Model
Edge
BioCryst Pharmaceuticals Inc
0001883764
Filing type
144
Filing date
May 17, 2026
Updated
May 18, 2026 ยท 2:48 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities